
Science
Experimental Pill Targets 'Undruggable' KRAS Mutations in Pancreatic Cancer
A new drug from Revolution Medicines uses molecular glue to bind with KRAS subtypes, targeting mutations long considered impossible to treat.
Topic
4 stories on biotechnology, across Science.

A new drug from Revolution Medicines uses molecular glue to bind with KRAS subtypes, targeting mutations long considered impossible to treat.

The Coalition for Epidemic Preparedness Innovations is funding three vaccine candidates to combat a raging Ebola outbreak in Africa.

The new open-source atlas surpasses the AlphaFold Database by more than 800 million entries, according to Biohub researchers.

The ESMFold2 model from Biohub provides an open-source alternative to AlphaFold, generating an atlas of over one billion predicted protein structures.